What the study looked at

• 100 postmenopausal women with disrupted sleep were randomized to estrogen therapy daily plus one of two progestogens for 3 months:
  • A synthetic progestogen comparator
  • Micronized progesterone
• Sleep quality was measured with the Pittsburgh Sleep Quality Index (PSQI) each month — a validated research tool where lower scores indicate better sleep.

What they found

• Both groups showed meaningful improvement in sleep quality.
  • Average PSQI improved from 10.5 → 4.9 with the synthetic progestogen and 10.2 → 6.3 with micronized progesterone.
  • The difference between the two groups was not statistically significant (p=0.08), meaning the trial couldn't confidently say one was better for sleep than the other.
• Side effects: The micronized progesterone group reported fewer overall side effects than the synthetic progestogen group.

What the research suggests

• This study adds to the body of evidence that progesterone may play a role in sleep quality during postmenopause — a connection researchers are increasingly interested in.
• Both progestogen types were associated with meaningful improvement in sleep quality scores over 3 months, with micronized progesterone possibly better tolerated.
• Important nuance: This trial tested progestogens added to estrogen therapy, not progestogen alone — so the improvements reflect the combination, not either hormone in isolation.

The short version: research suggests that when a progestogen is added to estrogen therapy in postmenopausal women, sleep quality scores may improve meaningfully over time — and micronized progesterone may come with fewer side effects than some alternatives. If sleep changes have been part of your midlife experience, this is the kind of research worth knowing about and worth discussing with your healthcare provider.